Matrix metalloproteinase-9 expression of GCTSC in peripheral tissue and central tissue of GCTB

被引:15
作者
Chen, Liang [1 ]
Zhang, Ji [2 ]
He, Yifeng [2 ]
Ding, Xiao-Yi [2 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Dept Radiol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Radiol, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China
关键词
giant cell tumor of bone; immunohistochemistry; MMP-9; RT-PCR; GIANT-CELL TUMOR; BONE; INVASION; MMP-9;
D O I
10.1002/jcb.26766
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Giant cell tumor stromal cell (GCTSC) is the tumor cell of giant cell tumor of bone (GCTB). The biomarkers characterization of GCTSC is critical for the selection of GCTB targeting drugs. We believe the main functions of GCTSC in different part of tumor should be different for different environment. Then the biological behavior and molecular biomarkers of GCTSC should be different as well. Based on this idea, we focused on GCTSC which located in central tissue, peripheral tissue and took MMP-9 as the breakthrough point to carry out research. The results showed MMP-9 staining grade of GCTSC which located in central tissue was slight, whereas multinucleated giant cell staining grade was high. The peripheral tissue was consisted by almost GCTSC with high MMP-9 staining degree and mRNA expression. This study also provided clues and inspiration for reducing GCTB recurrence rate after intralesional curettage with MMP-9 targeted therapy which were aimed at the residual peripheral tissue.
引用
收藏
页码:5805 / 5812
页数:8
相关论文
共 15 条
[1]   Expression of osteoclast differentiation signals by stromal elements of giant cell tumors [J].
Atkins, GJ ;
Haynes, DR ;
Graves, SE ;
Evdokiou, A ;
Hay, S ;
Bouralexis, S ;
Findlay, DM .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (04) :640-649
[2]   Gelatinase-mediated migration and invasion of cancer cells [J].
Björklund, M ;
Koivunen, E .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2005, 1755 (01) :37-69
[3]   GIANT-CELL TUMOR OF BONE [J].
CAMPANACCI, M ;
BALDINI, N ;
BORIANI, S ;
SUDANESE, A .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1987, 69A (01) :106-114
[4]   New functions for the matrix metalloproteinases in cancer progression [J].
Egeblad, M ;
Werb, Z .
NATURE REVIEWS CANCER, 2002, 2 (03) :161-174
[5]   Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-κB in giant cell tumor of bone -: Possible involvement in tumor cell-induced osteoclast-like cell formation [J].
Huang, L ;
Xu, JK ;
Wood, DJ ;
Zheng, MH .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (03) :761-767
[6]   Recurrent Giant Cell Tumor of Long Bones: Analysis of Surgical Management [J].
Klenke, Frank M. ;
Wenger, Doris E. ;
Inwards, Carrie Y. ;
Rose, Peter S. ;
Sim, Franklin H. .
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2011, 469 (04) :1181-1187
[7]   Local recurrence of giant cell tumor of bone after intralesional treatment with and without adjuvant therapy [J].
Knochentumoren, Arbeitsgemeinschaft .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2008, 90A (05) :1060-1067
[8]   Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions [J].
Kumta, SM ;
Huang, L ;
Cheng, YY ;
Chow, LTC ;
Lee, KM ;
Zheng, MH .
LIFE SCIENCES, 2003, 73 (11) :1427-1436
[9]   Treatment of stages 2 and 3 giant-cell tumor [J].
Labs, K ;
Perka, C ;
Schmidt, RG .
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY, 2001, 121 (1-2) :83-86
[10]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408